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The problem of lead ingestion, a major one to 
physicians and community leaders, has achieved increased 
prominence in the last several years. It is a problem 
that can be approached from many directions: clinical, 
biochemical, psychological, sociological, and political. 
The purpose of this paper is to look at some of the many 
clinical and biochemical parameters available for eval¬ 
uating a child suspected of lead ingestion and see which 
one, if any, would be valid for mass screening and which, 
as currently used, add little to the evaluation of the 
patient. 
Background material, including the magnitude of the 
"lead problem", pathophysiology of lead ingestion, and 
pertinent studies from the literature, will be discussed 
first, followed by our materials and methods, results 
and conclusions. Fortunately for the children there were 
insufficient numbers of lead intoxicated patients to 
draw many definite conclusions, however much of the data 
is guite suggestive and should add to our ability to 
evaluate lead ingesters. 
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The exact magnitude of lead ingestion is not known. 
In 1955-1963 in New york City 3% of the 60,000 reported 
pediatric poisonings were due to lead (1) and this has 
probably increased significantly with the recent vigor¬ 
ous campaign. It is predominantly a disease of urban 
slums with an estimated 15-25% of preschool children 
having increased absorption with about one-third of 
these having signs or symptoms of intoxication (2,3,7). 
Pica, which starts in the second year and extends through 
the fourth year of life is usually a key symptom in bring¬ 
ing the child to a doctor’s attention (5). It is estimat¬ 
ed that 10-30% (1,4,17) of children with pica have symptoms 
or signs of lead intoxication. Conversely,history of pica 
could only be elicited in 60% of cases when initially 
screened by an IYI.D. (6) 
Signs and symptoms: 
The signs and symptoms, which usually occur only 
after 3-6 months of ingestion, are protean (8). The 
symptomatic patient may present with insidious onset of 
abdominal pain with constipation or vomiting; anorexia, 
irritability, or symptoms of anemia. These may progress 
to clumsiness, lethargy, and even convulsions and coma (6, 
8,9,). Physical exam is usually unremarkable except for pallor 
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and, in cases of severe intoxication, signs of increased 
intracranial pressure. The encephalopathy is the most 
feared complication as at least 25% of survivors of enceph¬ 
alopathy sustain permanent brain damaqe such as seizures, 
mental retardation, specific learning deficits, or behav¬ 
ioral disorders(10). 
Fate of lead: 
Normally, the intake and output of lead are equal- 
what is ingested and inhaled is excreted in the urine 
and feces (12). Usually less than 1 mg/day of lead is 
ingested 90% of which is passed out in the stool (2). 
Kehoe, in his balance studies, states that the safe levels 
of ingestion are less than 1.3 mg/day. At an ingestion 
rate of 1.3 mg/day toxicity is reached in 7.5 years, at 
2.2 mg/day toxicity is reached in 3.9 years and at 3.2 mg/ 
day only 0.64 years are required to reach toxic levels (13). 
Therefore, those who consistently take in more than 2-3 
mg/day require about 6 months before lead levels become 
toxic. Of interest is the fact that the lead problem is 
worse in the summer, a fact attributable to an increase 
in Vitamin D in children exposed to the sun which leads 
to an increased GI absorption of lead (3). 
Once in the body the lead goes first into the soft 
tissues and quickly leaves and is transferred into! bone. 
The tissues most affected are liver, kidney and then 
brain with levels reaching 30 times those of controls (14), 
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Normal blood levels may aqain appear by 6-12 months 
after inqestion stops, when most of the lead is in the 
bones (2). However, a great deal of lead may be present 
and things that mobilize calcium may mobilize lead. 
Some of these include: low phosphate, intercurrent infect¬ 
ion, increased parathyroid hormone, increased Vitamin D, 
acid-base imbalance, or bone disease (2,15,16), The 
elimination of these accumulations of lead is primarily 
through the urine, Kehoe (12) showed that the time re¬ 
quired for elimination was at least two times that required 
for accumulation and was proportionately longer as the 
period of accumulation lengthened. One would then see 
urine levels decline rapidly after ingestion and then fall 
more gradually as the accumulated load is excreted. 
Lead: 
Lead levels in blood and urine have been widely 
used to evaluate potentially intoxicated patients. Since 
only blood levels were used in our study the discussion 
will be limited to them. 
Of primary importance in measuring blood levels is 
is that whole blood and not serum be used. In most 
studies 90-95% of lead is said to be bound to the red 
blood cell (11,14,15,18,19). It is bound as a sol and 
there is no inhibition of lead uptake by metals such as 
calcium (19). Implicit in the fact of red cell binding 
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is that a patient’s hematocrit must be taken into ac¬ 
count in blood lead levels (usually given in rnq/lOO gm 
of whole blood). 
What is considered a normal blood lead is quite 
variable. In most of the studies discussed below it is 
not clear whether or not blood leads were corrected for 
hematocrit and if so to what hematocrit they were cor¬ 
rected to, hence this adds to the confusion of "normal 
values". Although the methods of lead determination 
are not mentioned most of the methods were probably the 
Dithizone-colorimetric method which can detect to 0.2 ug 
+ or - 0.1 ug. (20) 
Various upper limits of normal in mq Pb/100 gm whole 
blood are:0.02 (14), 0.036 (17), 0.04 (10,15), 0.05 (22), 
0.06 (1,5,8,11,21). 0.06 seems to be the one most widely 
used. Values for definite toxic levels with risk of 
encephalitis was 0.08 (5,6,10) - 0.10 (2,4) and above. 
However, Bradley (22) in his study of 462 patients had 
12 of 27 patients with central nervous system symptoms, 
15 of 80 with gastrointestinal symptoms and 22 of 49 
with stippled red cells with values below his upper limit 
of normal of 0.05 mg%. Chisolm (15) points out that lead 
levels are affected by many factors including: hematocrit, 
intercurrent infection, coincident bone disease, current 
or recent administration of chelating agents, current or 
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excessive absorption of food, and time interval since 
excessive absorption ceased. For example, in a child 
with a blood level of 0.04- 0.08 mq% it is difficult 
on the basis of blood lead value alone to distinguish 
between temporary dietary change and increased body 
burden. He thus recommends that other parameters of 
lead's metabolic toxicity (e.g. urinary d-ALA) may be 
used as a more accurate index of soft tissue lead. 
Berman (14) further comments that blood lead levels 
indicate the degree of lead absorption but that these 
are of value only in acute cases since blood is rapidly 
cleared of lead. He found that blood levels in chronic 
cases are not remarkable. It seems, then, that blood 
levels, once the standard for lead toxicity, may be 
not entirely dependable in that: a) values are not 
always standardized for hematocrit, b) symptomatic and 
even toxic patients may have normal values and c) chronic 
ingesters may have normal values. 
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Toxic effects of lead 
Heme synthesis and anemia: 
One of the common findings in lead inqesters is 
anemia. Since iron deficiency is also fairly common in 
this age group (4,6) it will be worth while to discuss 
some of the mechanisms of lead anemia and the relation¬ 
ship to iron metabolism, 
figure 1 is a summary of heme synthesis. The current¬ 
ly accepted sites of action of lead are indicated (2,23, 
24), Lichtman and Feldman (23) showed that ALA-dehydrase 
activity is greatly reduced thereby producing and excess 
of deIta-amino—levulinic acid (ALA), The lead probably 
inactivates the sulfhydryl groups as this inhibition 
is reversed by preactivating the system with reduced 
glutathione. The second major step inhibited is the 
incorporation of iron into protoporphyrin 9 which ac¬ 
counts for the excess of protoporphyrin, Minor effects 
of lead on CPG oxidase or CPG decarboxylase is also seen, 
leading to an excess of coprporphyrin III, Lead pro¬ 
bably also decreases ALA synthesis but to a minor degree. 
Chisolm (25) has quantified the abnormal heme precursors 
and the reader is referred to this for specifics. 
Serum iron and percent saturation may be high or low. 
Iron absorption, transport and storage are unaffected 
in lead intoxication (31), Lichtman and Feldman studied 
effects of iron deficiency on heme synthesis and found no 
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effect of iron deficiency on ALA dehydrase. They 
found an i_n vitro decrease of porphyrin synthesis in 
iron deficiency that may have been due to a decrease 
in PBG deaminase or isomerase activity. Hence, iron 
levels may be high in lead poisoning from inhibition of 
iron incorporation into heme but levels are usually low 
due to iron deficiency (22). The iron deficiency itself, 
however, has little effect on heme synthesis. 
Other aspects of red cell dynamics are also affected. 
Severe anemia with severe erythrocytic hypoplasia of 
the bone marrow, reversible after treatment is reported 
in one boy (26), Leiken and Eng (29) did Fe^9 and Cr^l 
red cell kinetic studies on seven patients 1^-10 years 
old who had iron resistant anemia, pica, increased lead 
levels and X-ray evidence of excess lead ingestion. All 
patients had a normal or increased serum iron and sig¬ 
nificant stainable iron in the marrow. In patients with 
less than a one year history of ingestion a hemolytic 
picture was seen: increased iron incorporation, increased 
erythrocyte iron turnover, decreased RBC survival, and 
increased erythroid elements (decreased myeloid/erythroid 
ratio). In patients with a more than one year history 
a hypofunctioning marrow picture was seen: decreased 
iron incorporation, decreased erythrocytic iron turn¬ 
over, normal RBC survival, and a decreased erythroid 
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element of the marrow (increased ffl/E ratio). Other 
reported findings in lead poisoning are: decreased 
osmotic fragility, increased mechanical fragility (27, 
31), occassional positive Coombs test (31), normal hapto¬ 
globin levels (30,31), low hemog lob in , re d count, MCV,[YICH, 
MCHC, low percent saturation of iron binding capacity (28) 
and increased reticulocytes (4,28). It is noted that 
these findings are similar in iron deficiency (i.e, low 
hemoglobin, red count, MCV, MCH, WCHC, percent saturation 
of iron binding capacity) and it is to be remembered 
that iron deficiency often occurs in these patients. 
Differential may be made by the increased reticulocytes 
in plumbism compared to untreated iron deficiency, and 
mainly the finding of abnormal heme precursors in plumbism 
ALA : 
Delta-aminolevulinic acid, one of the heme pre¬ 
cursors elevated in lead intoxication, is fairly readily 
measurable in plasma or urine and is often one of the 
criteria used in evaluating lead intoxicated patients. 
The most widely used method, the Haeger-Aronson method, 
is sensitive to plasma ALA within 5% of ALA values 
above 0.03 mg/lOQ cc plasma or serum. Normal values, 
which depend on individual eguipment and standard curves, 
are: 0.019 +or- 0,004 <mq% (11) and 0.0114 +or- 0.0053 mq% 
(32). Chisolm, in a different method, had values of 
0.0056 +or- 0,00019 mq% (33). 
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In one study Chisolm (55) showed higher plasma ALA 
levels in patients with lead encephalopathy than in 
patients with acute lead intoxication but without enceph¬ 
alopathy. Both of these groups had higher levels than 
in totally asymptomatic patients with increased lead 
absorption. Feldman et al (32) have studied three 
groups of patients, broken down by clinical classific¬ 
ation, and has studied the ALA and lead values of these 
groups. Group I had elevated Pb (above 0.06 mg%) but no 
other clinical or laboratory signs of toxicity. Group II 
had elevated Pb and other laboratory evidence, and 
Group III had elevated Pb, other laboratory evidence, and 
encephalopathy. The results were: 
G roup Pb-mg/lOOml blood ALA- 
norma 1 less than 0.06 .0114 +/- .0053 
I .069 +/- .017 .0106 +/- .0062 
II .083 +/- .025 .0371 +/- .0014 
III .196 +/= .102 .0959 +/- .0491 
p less than ,05 p less than ,005 
There is good significance between the different groups 
with a greater degree of overlap in lead levels compared 
to ALA levels. The graph of serum ALA vs. Blood lead 
"suggested a positive relationship between the variab¬ 
les with wide scatter." The authors concluded that 
elevated blood lead levels indicate exposure to and 
increased absorption of lead and they do not necessarily 
indicate lead intoxication. On the basis of the fact 
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that the ALA values ofthe groups showed good separation 
and that all patients with stigmata of lead intoxication 
had elevated ALA levels he concluded that "the serum 
d-ALA level proved to be an extremely sensitive indicat¬ 
or of toxicity and appears to be useful in selecting 
patients who may reguire hospitalization and detox¬ 
ification with chelating agents (32)." 
Basophilic stippling: 
Basophilic stippled red cells are often seen in 
peripheral smears of lead intoxicated patients. From 
30% (5) to 60% (6,32,36) of patients are reported to 
have them although 800 stippled RBC/million RBC is said 
to be a normal finding (35). The granules are actually 
aggregations of RNA surrounding mitochondria (11, 25,27). 
These cells differ from mature cells in the following 
ways: 1) mature cells do not contain mitochondria and 
hence connot synthesize heme precursors, while these 
cells have mitochondria and can synthesize the precursors; 
2) mature cells consume little oxygen while basophilic 
stippled cells have higher consumption than mature cells 
and even higher than reticulocytes (25); 3) these cells 
contain more cytochrome C and adenine nucleotide than 
a mature cell (11). Hnece these cells are very active 
metabolica1ly. The basophilic stippled cells are probably 
destroyed in an increased rate by the reticuloendothelial 
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system as splenectomy or reticuloendothelial blockade 
with trypan blue produces a marked increase in the number 
of stippled cells in guinea pigs (28). These cells are 
different than reticulocytes and the number of retic¬ 
ulocytes does not correlate with the number of basophilic 
stippled red blood cells (4). 
The usefullness of these as a criterion for lead 
intoxication is questionable. Firstly, they are, as 
shown above, at best found in 40-60)£ of lead intoxicated 
patients. They do not correlate with intensity of exposure 
and may be seen in other disorders such as anemia, leuk¬ 
emia, thalassemia, or exposure to other compounds such as 
benzene, aniline, or carbon monoxide (27, 31). There is 
also no value in quantifying the number of stippled red 
cells as this can be changed by different staining and 
drying procedures. It is therefore suggested that the 
finding of these cells should arouse suspicion of lead 
intoxication and that more reliable studies should be 
subsequently done (34). 
Flourescent red cells: 
As indicated in Figure 1 there is an excess of 
erythrocyte protoporphyrin in lead poisoned patients. 
A property of this porphyrin, red flourescence under 
ultraviolet stimulation at approximately 400 mu, is the 
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basis for another test of lead poisoning- flourescence 
of erythrocytes. The flourescent cells are called 
flourescytes. 
The basic technique,described by Whitaker and 
Vietti (38) and subsequently modified, involves placing 
a drop of heparinized blood on a slide, suspending it in 
saline, looking at it under UV stimulation of approx¬ 
imately 400 mu, and counting the percent of f lourescytes. 
The counting must be done rapidly as the flourescence 
fades within 15 seconds when a mercury vapor source is 
used, which is the common light source. Cripps et al (40) 
reported longer flourescence with an iodine tungsten 
source but the papers reviewed here used the mercury 
vapor lamp. Whitaker and Vietti (38) found no floures- 
cytes in normal children, 0-50$ in iron deficient children, 
25-100$ in 12 treated lead poisoned patients, and 75- 
100$ in 7 untreated patients. Nelson's group (30) studied 
869 patients with anemia but with no lead poisoning and 
33 patients with proven lead poisoning. Of the 869 
with anemia 98.4$ had less than 1$ flourescence and only 
2 patients had greater than 5$ flourescytes. Of the 33 
patients with proven lead poisoning all but one had 
flourescytes (but this patient had them on repeated 
testing three days later) with 31 patients having more 
than 10$. He, therefore, called less than f% normal, 
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and greater than 10% lead poisoning with 2-10% being the 
gray zone. Using these limits of normal he found 
excellent correlation with % flourescytes and lead excre¬ 
tion after EDTA ( p less than .005) and an excellent 
correlation with erythrocyte protoporphyrin, the likely 
cause of the flourescence. He also showed that in 10 
patients followed up after treatment all had disap¬ 
pearance of flourescence with a mean time of 9.7 months. 
The lower ranges of flourescence in Nelson's paper is 
due to a second red excluding filter not used by Whitaker 
and Vietti. Both studies seemed to imply that this is 
a good screening test. Nelson et al gave the normal 
range as listed above and recommended work up of anyone 
with greater than 5% flourescytes. It must be remember¬ 
ed that in initial screening 1 of 33 patients with 
proven lead poisoning had less than 1% flourescence- 
a false negative in 3% of cases. Other editorials on 
lead poisoning (10) comment that this is probably a 
good technigue for those skilled in it but that it is 
not potentially useful for general hospital laboratories, 
Lead hemoglobin: 
A final hematological finding in approximately 
50% (31) of intoxicated patients is that of lead hemo¬ 
globin. Charache (37), doing hemoglobin electrophoresis 
at pH 8.6, found that in 10 of 24 lead poisoned patients 
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there was a component that migrated in front of the 
major hemoglobin component. This was called lead 
hemoglobin (Hb-Pb) which seems to be identical to Hb-A^ 
which normally is seen in senescent red cells. The 
mechanism of its production is not known but it is not 
seen in iron deficient patients without lead poisoning. 
If the Hb-Pb represents Hb-A^, which it most probably 
does, it may indicate premature senescence of the red 
cell in lead poisoning. 
Effects on renal function: 
The reports of the effects of lead on the kidney 
have varied. Earlier reports of a twenty year follow 
up of lead poisoned children in Queensland, Australia 
stated that 101 of 165 patients who died had "nephritis 
or renal sclerosis" (41). Taper, however, in his twenty 
year follow up of 42 lead intoxicated patients in Mass¬ 
achusetts found no evidence of chronic renal disease (41). 
Illis (42) found abnormal blood ureas and creatinines 
in lead workers who had increased lead absorption (ele¬ 
vated lead in urine). Henderson (43) found higher bone 
lead in patients with chronic renal disease of unknown 
origin than in patients with either no renal disease or 
with renal disease of certain origin other than lead 
poisoning. Increased incidence of gout in chronic 
lead ingesters, by a mechanism to be described below, 
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has also been reported by various authors (44, 45, 46). 
It therefore seems that lead ingestion may lead to an 
increased incidence of chronic renal disease. 
A second important question is whether or not there 
is evidence of change of renal function in acute lead 
intoxication. Smith (36) reported that albuminuria or 
glycosuria is present to a slight degree in 30% of 
childhood lead intoxications. Chisolm (47) reported 
aminoaciduria, glycosuria, and hypophosphatemia-* the 
Fanconi syndrome- in 9 of 23 lead intoxicated patients 
before EDTA treatment. In the remaining 14 patients 
there was varying degrees of aminoaciduria correspond¬ 
ing to the clinical severity of the intoxication. Hence 
it seems from these reports that a change of renal funct¬ 
ion is readily apparent in 1/3 to 1/2 of the lead 
poisoned patients. It must be remembered that EDTA 
may cause aminoaciduria itself (16) but in these studies 
the urine tests were done before administration of 
EDTA. However, in Chisolm's study (47) the aminoacid¬ 
uria cleared after 24 hours of administration of EDTA. 
There have been varied descriptions of the site of 
action of the lead in nephropathy. Intranuclear inclusions 
were seen in the proximal tubule cells (2,11,45,47,48), 
as well as in the nuclei of other body cells- liver, 
pancreas, and brain (2). Electron micrographs (49) have 
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shown changes in the epithelial cells identical to those 
of lipoid nephrosis in four humans with proteinuria and 
lead poisoning. The tubular lesions are said to be rever¬ 
sible (11,47) however in chronic poisoning vascular lesions 
with development of nephrosclerosis may occur (11). 
The pathophysiologic changes involve primarily the 
tubules. Chisolm (47) that while normally 95-99% of 
filtered amino acids are reabsorbed less than 90% are 
reabsorbed in acute plumbism. The incidence of gout is 
remarkably elevated in patients with lead nephropathy. 
Emmerson (46) showed that 16 of 33 patients with chronic 
lead nephropathy had gout while only 1 of 18 with non¬ 
lead nephropathy had it. Of interest is that 7 of 19 
females with lead nephropathy had gout. Uric acid 
balance studies by Emmerson (44) and Ball (45) showed; 
1) no increase in uric acid production; 2) normal tubular 
reabsorption of uric acid; 3) marked defect in tubular 
secretion of uric acid; 4) fall in urate clearance out 
of proportion to the decrease in clearance of creatinine 
and inulin. Number 3 above appears to be the mechanism 
of the increased incidence of gout in chronic lead 
nephritis. 
In acute lead poisoning, then, one may see amino¬ 
aciduria, glycosuria, and proteinuria from tubular lesions 
and possibly glomerular lesions which may be reversible. 
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In chronic lead nephropathy, from prolonqed ingestion 
and/or irreversible damage to the tubules, a decreased 
tubular secretion of uric acid is seen with elevated 
serum uric acid levels. Elevated blood urea and creatin¬ 
ine levels, also evidence of chronic renal disease, may 
be seen. 
Encepha lopathy: 
Encephalopathy is one of the feared complications 
of lead ingestion and intoxication. Acute encephal¬ 
opathy has a mortality rate of 20% or more (2) while at 
least 25% of the survivors sustain permanent brain damage 
such as seizures, mental retardation, specific learning 
deficits, or behavioral disorders (10). The lesions 
caused by the lead are due to increased capillary 
permeability and petechial hemorrhages which cause 
death of neurons and formation of cerebral edema (3). 
The patient will have symptoms of encephalopathy, along 
with increased cerebrospinal fluid pressure, protein 
and cells, usually lymphocytes (4). 
X-rays of bones and abdomen: 
Radiologists often look for evidence of lead 
ingestion in the abdomen and ends of long bones. Radiopa¬ 
que flecks in the abdomen are seen in approximately 50% 
of cases (10,36), Since lead is radiopaque these are 
thought to represent lead, but non-lead materials may 
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show (8). The nature of the lead line is not exactly 
clear. Kissane and Smith (63) suggest that it is due to 
subepiphysea1 zone of provisionly calcified osteoid in 
which metaplasia to form cancellous bone is retarded, 
Chisolm (2) says that storage of excess lead in bone pro¬ 
duces the characteristic radiologic changes in the meta- 
physes of long bones and that the broad band reflects 
the densely packed, irregular trabecular structure of 
bone being formed in the presence of excess lead. Ander¬ 
son (65) comments that dense lines are often seen in ab¬ 
normal absorption and storage of heavy metals. Others 
(8,16,64) say it is due to deposition of lead in the 
epiphyses and "must be distinguished from growth arrest 
lines (8)". Sartain’s (51) study of X-ray findings in 
acute and chronic lead ingesters and in normals showed 
the following: chronic ingesters- 2 definite positives, 
7 eguivocal, 5 normals (36%0; acute ingesters- 1 positive, 
3 eguivocal, 10 normal (72%); normal controls- 3 equivocal, 
11 normal (79%). He showed that it usually requires 
six months of ingestion for lead lines to appear, that 
lines may be absent early in the course, and that false 
positives may occur. The logical conclusion was that 
x-ray findings should be a secondary consideration and 
that their absence should not preclude further study nor 
should their presence be taken as proof of intoxication. 
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Misce1laneous : 
Various other effects of lead ingestion have been 
looked at, Kopito (52) studied the lead concentration 
of hair. Since absolute amounts of hair lead varied with 
environment two or more adjacent hair segments, 5-10 mm 
long, were studied. An increased concentration was seen 
near the scalp in acute ingestion, while a generalized 
increase was found in chronic ingestion. He found that 
hair lead correlated well with urine and blood lead. 
Sanstead (53) studied thyroid function in 24 patients 
with excess lead ingestion from moonshine whisky and 
found injury to iodine trapping and concentrating mech¬ 
anisms. 'Yluro (54) studied chromosomal damage in rats 
fed lead salts. Those fed salts for prolonged periods 
developed renal adenomas, renal adenocarcinomas, de¬ 
creased fertility, increased frequency of abortions and 
miscarriages, and increased congenital malformations. 
Examination of leukocytes from 10 male and 10 female rats 
fed lead acetate for two weeks showed an increased 
number of abnormal chromosomes compared to controls. These 
included gaps, breaks, and fragments. It was seen earlier 
in the renal section that lead morphologically affects 
nuclei of human cells, therefore, chromosome studies like 
these may become increasingly significant in the future. 
Of passing interest is the relationship of the symp¬ 
toms of lead poisoning to those of acute intermittent 
porphyria (AIP) (58) both of which have abnormal por- 
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phyrin metabolism. Both have GI symptoms of abdominal 
pain, constipation, and vomiting. The nervous system siqns 
differ: plumbism has central signs of motor incoordination, 
and lethargy while in AIP psychiatric symptoms are more 
common. Both have increased urine ALA, however AIP has a 
marked increase in urine porphobilinogen compared to lead 
poisoning while urine coproporphyrin is markedly increas¬ 
ed in plumbism compared to AIP. It is therefore inter¬ 
esting to speculate on the causal effect of the abnormal 
porphyrin metabolism on symptoms of lead intoxication. 
This study did not deal with the treatment of lead 
intoxication and the reader is referred to Chisolm's (55) 
article on this subject. 
The relative merits of the different parameters, the 
determination of which is the purpose of this paper, was 
difficult to ascertain from the literature as few authors 
looked at many parameters at once. One paper (56) chose 
blood lead over urine lead, urine ALA and basophilic stip¬ 
pling, with hemoglobin determination being of no merit. 
Another qroup (57) chose serum ALA over urine ALA, 
urine lead or other urine porphyrins. The merits of the 
other tests, mentioned above, will be reevaluated in the 
discussion of our results later in the paper. 
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materials and methods 
Patients: 
There were 66 patients studied- 35 males, 28 females 
with three patients being done on 2 separate occassions. 
The mean age was 32.5 months with the distribution as 
noted in Figure 2. The patients were selected on the 
basis of their being potentially lead intoxicated. 
These included patients with: previous history of lead 
inqestion; those who were related to lead ingesters; 
patients with a questionable history or definite history 
of pica; and patients with unexplained central nervous 
system symptoms such as lethargy. 
Samples: 
From each patient, whenever possible, 25-30 cc of 
blood were drawn. 12 cc were sent to the state labor¬ 
atory for lead analysis, 8-10 cc were sent to the clinical 
chemistry lab for iron, iron binding capacity, and uric 
acid, and 5-10cc were sent to our lab for tha other analy¬ 
ses. Since blood samples were often difficult to obtain 
from the young patients; at times insufficient amounts of 
blood were sent to our laboratory hence we frequently had 
insufficient samples on which to assay for ALA. 
Urine samples were difficult to obtain because of 
the age group and the fact that many patients were out¬ 
patients and were unable to void while at clinic. When 
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possible 5-10 cc were obtained and these were tested as 
described below. 
Lumbar punctures were done on patients with elevated 
blood lead levels. Samples were obtained by the house 
officers. 
All blood tests, with the exception of serum ALA, 
hemoqlobin electrophoresis, and flourescytes, were done 
within 6-8 hours of collection during which time the whole 
blood was refrigerated. The plasma and cells were separ¬ 
ated within 6-8 hours of obtaining the samples and the 
cells were refrigerated for flourescyte screening, done 
within 24 hours, and the serum was frozen for ALA determin¬ 
ation, done within 2 hours of thawing the sample. The 
aliquot of cells for electrophoresis was washed and 
refrigerated until the electrophoresis was done, which 
was usually done on a once per week schedule. 
History: 
All the patient's charts were reviewed and perti¬ 
nent history was obtained from them including history of 
pica, other hematological or pertinent medical history, 
and X-ray reports. 
Laboratory studies: 
Blood: studies done by the hospital laboratory were: 
1) Red and white blood counts were done in duplicate 
by Coulter Counter. 
2) Serum iron- released iron measured as iron-batho- 
phenathrolone complex color reagent. Iron binding capac¬ 
ity (IBC)- protein saturated with iron and measured as iron. 
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Normal values: Fe(ug %)- males- 60-180 females-50-170 
IBC(um %)- males and females- 248-422 
3) Uric acid by urease method. 
Normal values (mq/6)- male-4.5-6.5 females 2.5-5.5 
Studies done by our laboratory: 
1) Hemoglobin in duplicate as cyanomethemoglobin 
2) Hematocrit- in duplicate by capillary tube 
3) Indices- calculated by the standard methods 
4) Basophilic stippled red blood cells- 
Smear stained with Wright’s stain for 3 minutes, Wright's 
buffer for 6 minutes and the number of stippled cells 
per 1000 total cells were counted. Distorted cells or 
cells in an area of the slide with excess stain were 
not counted, 
5) Reticuloeytes- 
Equal amounts of freshly filtered new methylene blue and 
whole blood were allowed to stand for 15 minutes. One 
drop was then smeared on a slide and 1000 cells were counted. 
6) Hemoglobin electrophoresis- 
Starch block at pH 8.6 allowed to run at least 16 hours. 
Quantification was done byeluting the individual zones 
with distilled water and the percent of hemoglobin in 
each band was calculated after measurement of hemoglobin 
as described above. 
7) Plasma ALA- 
Wodification of the Haeger-Aronsen (11) method done so 
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that only 2 cc of plasma needed. Below is listed only 
the volume differences from the standard methods; 
1) 0.1 ml freshly prepared iodoacetamide 
+ 1 ml serum 
2) 0.5 ml 20% trichloroacetic acid added after 2 minutes 
3) 0.5 ml supernatant + 
0.5 ml acetate buffer pH 4.6 
0.05 ml 2.5l\! NaOH 
0.03ml acety lacetone (omitted from control) 
4) 0.75 ml of above solution+ 
0.75 ml Ehrlich's reagent II 
A standard curve was made with ALA-HC1, A grade from 
Calbiochem. The gm ALA/gm ALA-HC1 was taken into 
account in the standard curve. The optical density was 
read in a 1 cm light path by a Hitachi-Perkins Elmer 
(Coleman 111) spectrophotometer. The standard curve is 
shown in figure 3. ALA= 0.D./0.6 
Control; a 250 cc sample of blood bank plasma was divided 
into 3 cc aliguots which were frozen. One or two of the 
aliquots were run with each group af ALAs. The control 
had a mean of 0.037 mg% with a range of 0.035-0.039. 
Therefore the values differed at worst by only 10% (all 
values were + or - 5% of the mean). 
8) Elourescytes- 
A Zeiss microscope with a Vorshaltegrat U. Drossel 
mercury vapor UV light source was used. A schott 8C-12 
filter was used with a maximum transmitted wavelength of 
400 mu. Magnification was 512x. 
Method: One drop of anticoagulated blood was mixed with 
saline. 50 high power fields were scanned for presence of 
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any flourescence. If any was found a second slide was 
prepared a 5 cells in 40 different fields were counted 
and the percent flourence was counted. A second red 
excluding filter was not needed as the cells had distinct 
flourence with no red tinge on cells fron normal controls. 
9) Blood lead- 
Assay was done by the State of Connecticut laboratories 
by a modification of the Cholak method (61). Their 
upper limit of normal was 0,Q^ mg/100 ml blood but their 
values were not corrected for hematocrit. 
**In this stidy all of the lead values have been standard¬ 
ized to a hematocrit of 35/6. 
Urine : 
1) Urinalysis-glucose,protein determined with Ames Combistix 
2) Urinary amino acids- were done and interpreted by 
the Yale genetics laboratory. 
Cerebrospinal fluid: 
1) Protein, glucose, and cells done by hospital laboratory. 
Statistics: 
Means, standard deviations, correlation coefficients, and 
probabilities were done by standard statistical methods 
(60,62). Calculations were done by IBM computer. When 
two variables were being correlated any unpaired number 
was omitted from the calculations. 
r : 
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In this section the data will be presented, for 
simplicity, primarily in graphic and table form. The 
"raw" data is listed in Appendix 1. The graphs and 
tables are set up so that the following questions 
could best be answered: 1) Which of the three, serum 
ALA, blood lead, or percent flourescytes is a better 
criterion for evaluating and screening the lead intox¬ 
icated patient; 2) Assuming our normal range for ALA is 
less than 0.095 mg/100 ml plasma, our normal range for 
lead is less than 0.06 mg/100 ml blood, and our abnormal 
range for flourescence is any flourescence, how valuable 
are the other parameters, that is how often do they give 
true positives, true negatives, false positives, and 
false negatives. 
The normal range for lead is the one suggested by 
most studies (1,5,8,11,21). All the lead values in our 
results have been standardized to a hematocrit of 35%. 
The normal range of ALA differs from the ones cited. 
However, as will be seen from the data, it arbitrarily 
appears to be the best cut-off point. In one study (39) 
the normal value for flourescytes is less than 1%. In our 
results we arbitrarily used the presence of any flour¬ 
escence as being significant as quantification is diffi¬ 
cult due to the rapid fading of flourescence and we were 
looking for a rapid screening method. 
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Figure 4_- Corre lat ion of variab les 
As described in the methods the various parameters 
were correlated according to standard statistical methods. 
Only paired samples were used so when two parameters 
were correlated all unpaired numbers were deleted from 
that calculation. This accounts for the change of mean 
and standard deviation when a variable was used in 
different calculations. 
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Fiqure 5- A LA vs Pb_ 
The graph of ALA in mg/100 ml plasma vs Pb in mg/190 ml 
blood shows: 
1) Assuming lead is the standard of true intoxication 
with Pb greater than 0.06 being abnormal, then the accuracy 
of ALA as a test is considered with ALA greater than 0.095 
as an abnormal value. Therefore: 
with ALA greater Pb greater than .06- 10 
than .095 - Pb less than .06 - 1 
with ALA less 
than .095 - Pb greater than .06- 1 
Pb less than .06 - 32 
Therefore: 
True positives - 10 
True negatives - 32 
False positives- 1 
False negatives- 1 
2) Conversely, assuming ALA is the standard of intoxic¬ 
ation with ALA greater than 0.095 being abnormal, then the 
accuracy of Pb as a test is considered with Pb greater 
than 0.06 as an abnormal value. Therefore: 
with Pb greater ALA greater than ,095- 10 
than .06 - ALA less than .095 * 1 
with Pb less 
than .06 - ALA greater than .095- 1 
ALA less than .095 - 32 
Therefore: 
True positives - 10 
True negatives - 32 
False positives- 1 
False negatives- 1 
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Fiqure 6- Flourescytes vs Pb 
The graph of flourescytes in percent vs pb in mq/100 ml 
shouts: 
1) Assuming Pb is the standard of intoxication with values 
greater than 0.06 being abnormal, then the accuracy of 
flourescytes as a test is considered with any flourescence 
being abnormal. Therefore: 
With Pb greater flourescence present- 10 
than .06 - flourescence absent - 2 
with Pb less 
than .06 - flourescence present- 2 
flourescence absent - 46 
Or: 
True positives - 10 
True negatives - 46 
False positives- 2 
False negatives- 2 
2) Conversely, using flourescytes as the standard, and 
testing the accuracy of lead levels, with the ranges of 
normal as above, there are: 
True positives - 10 
True negatives - 46 
False positives- 2 
False negatives- 2 
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riqure 7- Flourescytes vs A LA 
The graph is of flourescytes in percent vs ALA in mg%, 
1) Assuming ALA is the standard of true intoxication 
with abnormal values being those above 0.095 then the 
accuracy of flourescytes as a test is considered with 
the presence of any flourescence being abnormal. 
Therefore: 
with ALA greater 
than .095 
with ALA less 
than .095 
0 r: 
True positives - 8 
True negatives -34 
False positives- 2 
False negatives- 3L 
flourescence present - 3 
flourescence absent - 
flourescence present - 2 
flourescence absent -34 
assume 2) Now, using the same normal ranges as above 
flourescytes to be the standard of intoxication and 
consider the accuracy of ALA as a test. One sees: 
True positives - 8 
True negatives -34 
False positives- £L 
False negatives- 2 
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rigure _fl, A&B- Basophilic stippling vs Pb, A LA 
A) Basophilic stippling in % vs Pb in mg/100 ml blood 
B) Basophilic stippling in % vs ALA in n\q% 
A) Assuming lead is the standard of intoxication with 
values above 0.06 as abnormals, the accuracy of baso¬ 
philic stippling as a test is considered with any 
stippling as abnormal. Therefore: 
with Pb greater 
than .06 
with Pb less 
than ,06 
Therefore there are: 
True positives - 3 
True negatives - 40 
False positives- 0 
False negatives- 7 
stippling present - 3 
stippling absent - 7 
stippling present - 0 
stippling absent -40 
B) Now with ALA as the standard with an abnormal range 
of greater than .005, basophilic stippling is again 
considered with the presence of any stippling being 
abnormal. One sees: 
with ALA greater 
than .095 
with ALA less 
than .095 
stippling present - 3 
stippling absent - 5 
stippling present - 0 
stippling absent -28 
0 r 
True positives - 3 
True negatives - 28 
False positives- 0 
False negatives- 5 
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Figure 9, A&8 - Pica vs Pb_, A LA 
A) Presence of history of pica vs Pb in mg/100 ml blood 
B) Presence of history of pica vs ALA in mg% 
A) Assuming Pb is the criterion for true intoxication 
with values above 0,06 being abnormal, then pica is 
present or absent in the following ranges: 
with Pb qreater pica present -fO 
than .06 - pica absent -- 0 
with Pb less 
than .06 - pica present -25 
pica absent -15 
Or: 
True positives - !0 
True negatives - 15 
Fa Ise positives- 25 
Fa Ise negatives- 0 
8) If ALA is the standard for true intoxication with 
ALA greater than 0.095 being abnormal, then pica is 
present or absent in the following ranges: 
with ALA greater 
than ,095 
pica present - 
pica absent - 0 
with ALA less 
than ,095 
pica present -19 
pica absent -10 
Therefore: 
True positives - % 
True negatives - 10 
False positives- 19 
False negatives- 0 
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Figure 10, A£B- X-ray findings 
A) X-rays of abdomen 
B) X-rays of wrist 
In both these section positive and negative X-rays are 
correlated with Pb , ALA, and flourescytes. Abnormal 
ranges are: Pb greater than 0,06 mg/100 ml blood; 
ALA greater than 0,095 mq%; flourescytes- any present. 
A) X-ray of abdomen; 
1) with Pb greater 
than .06 
with Pb less 
than .06 
2) with ALA greater 
than .095 
with ALA less 
than .095 








Therefore: Pb ALA Flourescytes 
True positives - 8 
True negatives - 7 
False positives- 5 
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B) X-ray of 
1 ) with Pb greater 
than .06 
with Pb less 
than .06 
2) with ALA greater 
than .095 
with ALA less 
than .095 











Therefore: Pb ALA Flourescytes 
True positives 1 1 
True negatives 8 5 
False positives- 1 1 
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Figure 11- Basophilic stippling vs flourescytes 
Listed below is the comparison between basophilic 
stippling and flourescytes in the individual patients. 
Values are given in percents with abnormal being any 
flourescence or any basophilic stippling. 
Stippled cells Flourescytes Number of pairs 
1 ) positive positive 3 
1 .0% 3 5% 
0.5% 42% 
0.25% 5% 
2) positive negative 0 
3) negative positive 6 
0 2% 
0 1 .5% 
0 44% 
0 1 .5% 
0 14% 
0 1% 
4) negative negative 41 
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Fiqure 12- Cerebrospina1 fluid vs Pb, A LA, flourescytes 
Elevated CSF protein is taken to be greater than 40 mg%. 
Other abnormal values: Pb above 0.06 mq/lQO ml blood; 
ALA above 0.095 mg%; flourescytes any present. Only 
13 patients had lumbar punctures, only 2 of which had 
elevated proteins. 
CSF proteins 
1 ) with Pb greater 
than .06 
with Pb less 
than .06 
2) with ALA greater 
than .095 
with ALA less 
than .095 










Or simply: all those with abnormal CSF protein had all 
three parameters abnormal (Pb, ALA, flourescytes) but 
some patients with normal CSF values had one or more 
of the parameters in the abnormal range. 
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Fiqure 12 
CSF 
protein Pb ALA floures 
58 0.12 0.099 1 .5/o 
42 0.11 0.117 4 2% 
21 0.165 0.15 14% 
21 0.14 0.142 10% 
21 0.21 0.12 1% 
17 0.53 0.10 5% 
17 0.069 0.097 35% 
15 0.069 0.103 0% 
13 0.023 0.092 0% 
20 0.042 - 0% 
11 0.051 0.067 0% 
8.5 0.053 0.057 0% 
7 0.051 0.058 0% 
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Figure 13- Electrophoresis vs Pb, A LA, and flourescytes 
Two patients had the electrophoretic patterns with Hb-Pb 
(Hb-A3) as shown in Figure 11. In addition there were 
8 patients with Pb greater than 0.06 with no Hb-Pb; 
6 patients with ALA greater than 0.095 with no Hb-Pb; and 
9 patients with positive flourescytes with no Hb-Pb. 
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a2 A A 3 
Patients 1 and 2 have a zone that migrated beyond the 
major hemoglobin zone. This is the A3 band and represents 
lead hemoglobin. Patient 4 had Hb-AC. 
Laboratory values on patients 1 and 2: 
# A1 A 2 A3 Hgb total Pb ALA Floures , 
1 84% 3% 13% 7.8 .165 .15 14% 
2 88% 2% 10% 7.4 .53 .10 5% 
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Discussion and Conclusions 
As stated in the introduction, the purpose of this 
study is to determine which of the parameters investig¬ 
ated would be good for evaluation and/or screening of 
potential lead intoxicated patients and which parameters 
offer little to the evaluation of the lead intoxicated 
patients. 
The three major parameters studied were blood lead, 
serum ALA, and flourescytes. The results were set up in 
such a manner that each of the above parameters could be 
considered the true measure of lead intoxication (although 
none probably exists) and the other parameters were then 
viewed in relation to the "true" parameter. The most 
important criteria for calling a given parameter a good 
test is that it minimizes the number of false negatives 
(those patients whose values are normal yet who are intox¬ 
icated) without including too many false positives( those 
patients with abnormal values yet who are normal). 
False positives are not a terrible problem if the test 
is inexpensive- that is a) if it is not overly time cons¬ 
uming for the tester or the patient and b) if it is not 
too costly financially. False negatives, however, are 
dangerous . 
Other considerations for a good test are: 1) a test 
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that is not too complex and therefore not subject to 
procedural error; 2) a test that is reproducible within 
good limits; 3) a test that enables relatively easy 
attainment of sample material from the patient; 4) a 
test that can yield rapid results; 5) a test that is 
relatively specific for the condition being evaluated. 
As was also stated in the introduction there was an 
insufficient number of lead intoxicated patients to draw 
definite conclusions. Therefore, an attempt will be made 
to make as many inferences as possible. 
Lead, ALA, and flourescytes are used as the most 
specific criteria for lead intoxication since these 
most specifically measure V the effect of lead ingesti-on 
a) by showing elevated levels of body lead through blood 
lead levels or b) by showing the effects of abnormal 
porphyrin metabolism in lead intoxication through 
ALA levels or the presence of flourescytes. 
The sampling was bias by design. Only the potential 
lead intoxicated patients, defined in Materials and Meth¬ 
ods, were studied. Therefore, the percent of positives 
of a certain variable does not reflect the number of 
positives that would be found in the population at large. 
With the knowledge that this is a biased study designed 
to look for lead intoxicated patients we found: 1) 66 
patient samples were done; 2) of 62 who were tested for 
lead levels 14 {22%) were abnormal; 3) of 4? screened for 
ALA 11 (23%) were abnormal and 4) of 64 screened with 
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flourescytes 13 (20%) mere positive. Hence, with a 
biased test approximately 20-25% mere positive. 
Before discussing the specific results and questions 
above a fern general points will be considered. Later, 
the other parameters besides Pb, ALA, and flourescytes 
mill be discussed and their relative worth will be consid¬ 
ered. 
Normal values: 
The abnormal values used in this study mere: 
Pb greater than 0.06 mg/100 ml blood; ALA greater than 
0.095 mg %; flourescytes- any present. As explained 
earlier this value for lead if the most commonly accepted 
one. In looking at our graphs, Figure 4 for example, 
me see there mould be little to gain by lomering this 
number and much to lose by raising it. In Figure 4 a 
drop of the Pb normal range to .05 mould include no 
additional positive ALAs ( that is mould not eliminate 
false negatives) yet 6 additional false positives mould 
be included. Similarly, lomering the ALA value to .08 
mould pick up one false negative lead but mould also 
include 8 additional false positives. In Figure 6, a 
lomering of the normal Pb level to .05 mould pick up 
one additional positive flourescyte along with 8 patients 
mithout them (false positives). Figure 7 shoms, analagous- 
ly, that lomering the ALA normal to ,08 mould pick up 
no additional positive flourescytes (false negatives) 
.b079 
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but would pick up 8 false positives. By similar arquments 
it is seen that raising the limits of Pb or ALA would 
serve to eliminate true positives, which is, obviously, 
unacceptable. 
The normal for flourescence is very conveniently 
set at any flourescence. Since, as mentioned previously, 
quantification of flourescytes is both time consuming and 
difficult due to fading af flourescence there is little 
to be gained by doing it. Since it is being used only 
as a screening test one could rapidly look at a slide 
and if flourescence is present further evaluation could 
be done. Furthermore, by looking at Figures 6 and 7 it 
is seen that there does not appear to be a good direct 
correlation between ALAorPb and flourescytes- another 
argument aqainst quantification. The last point will 
be discussed in greater detail later but suffice it to 
say that quantification of flourescytes is fairly difficult 
and relatively useless. 
The normal values for ALA in the literature are: 
0.019 mg%( Haeger-Aronsen, 11); 0.014 mq1^ (Feldman, 32); 
0.0-56 mg% (Chisolm, 33). Our value was 0.095 mg'/o. In 
our standard curve, which was done from the beginning on 
six separate occassions, our slope was consistently 0.6 
compared to Haeqer-Aronsen' s (11) slpoe of 1.06. Our normal 
controls were very reproducible with all values beinq 
within 5% of the mean. Hence, what error, if any, was 
ieiiris vc Mlrt 8 «*» blu0" <ud 
.vl u iivdo . 1 r^oirfi*i ^anviiiaoa suii sisnimila o4 9\nse 
.9Ideiqsooenu 
.9on93seiur; ys 4b 4qb 
iuoI^ pnibs": oi sub ‘luoi *^ib 
-ii gnicb yd benlsp sd oi 
4b >iooI yltlasi bruoo Rno ieei pninssios 6 ee 
inessiq si sonsossiuol' U bns 
4b pni>iooI yd .siomiediiul .snob sd 
id oi isciqqs ion ssob 9isrii isdi nses si 
f'iv9?riuoI ^ bns dc;io JA nsewisd nolislsnoo 
.noliBal^liriBup dsnispB dnarrupifs 
eip ni bsseuoeib sd 
H 3o nniisoi^iinsup iedi yss 
, 8ssipsu yleviifilei bns 
JA -io^ ssulsv Ismion sdT 
»rvi ; r r r ^nsenoiA-ieossH^pin PtO.D 
. { EE , mI oeid 3) ^ pm 35-0.0 
sdi Di'i s »oh esw doirlut ,nvm)o bisbnsis itjo 
oisssooo sisicqss xis 
e issnoiA-ispseH ni bsisantop 
(It: diltu s cliou mqsi yisv eisw slminoo 
. nssm sdi kE nidiiut 
45 
made was made consistently and our normal, though different 
from the published normals, was consistent. Therefore, 
our range will be used. One guestion that must be raised 
and that was not clearly answered in the literature, was 
how Haeger»Aronsen and Feldman read values in the range 
of 0.01 With the volumes of serum used (3 ml), with 
a standard ALA curve of AIA= O.D. x 1.06, and with a 
Reckman spectrpphotometer, the values had to have been 
in the O.D. range of 0.01 which is a difficult range in 
which to read. 
Pb vs ALA 
Figure 5 considers these parameters against each 
other. It shows that when each is considered the "true" 
standard of lead intoxication the other gives 1 false 
negative and 1 false positive out of 11 possible positives. 
With lead as the standard the false negative with ALA 
(patient #65 Pb= .095, ALA= .083) the test for flourescytes 
was not done therefore we have no supporting evidence 
as to whether or not this is a true false negative. In 
the false negative with ALA as the standard (patient #25 
Pb= .048 ALA= .103) there were no flourescytes found. 
This suggests that this may be a real negative, that Is 
not a false negative, hence the lead value for this 
patient may have more validity. However, the number of 
cases is inconclusive to suggest one as a better parameter 
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hence it will be called a "draw". 
Figure 4 correlates ALA vs Pb and shows that the 
probability of these two parameters measuring different 
things is small ( less than ,001), That is the probabil 
ity is greater than 99,99/6 that they are measuring the 
same thing- lead intoxication, 
Pb or ALA vs other parameters: 
The remainder of Figure 4 gives correlations of 
variables not necessarily affected directly by ingest¬ 
ion but which are often changed in lead ingesters. The 
mean and standard deviation of the variables are also 
listed. Some of the variables, particularly lead, have 
a large standard deviation. It must be remembered that 
the standard deviation only measures the range of the 
variable, that is its spread about the mean. The large 
standard deviation of lead is due primarily to some of 
the very high values like .21, .46, .53. In the calcul¬ 
ation of correlation coefficient the standard deviation 
is taken into account hence even with these large spread 
of values many of the correlations are still excellent. 
The variables correlated first are Pb vs Hemoglobin 
TICHC, % iron saturation of iron binding globulin, and 
reticulocytes, that is lead is the "standard". As can 
been seen there is a significant correltaion between Pb 
and Hgb, not unexpected in light of the effect of lead 
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on heme synthesis as shown previously in Figure 1. The 
correlation of Pb with % sat, is fair and this may reflect 
a coexistence of the diseases in a population prone to 
iron deficiency and lead intoxication. The other para¬ 
meters, PflCHC and reties, do not correlate particularly 
well. Next ALA is the ’’standard'1 against Hgb, MCHC, 
% sat, and reties, ALA correlates will against Hgb, as 
may be expected since both are intimately related to each 
other (Figure 1) and both are affected by lead. There 
is an unexpectedly good positive correlation with reties. 
This is interesting because on page 10 it was noted that 
lead intoxication results in increased reticulocytosis (4, 
28). Since ALA gives a good correlation with reticulocytes 
one may surmise two events: 1) that the increased retic¬ 
ulocytosis occurs only after lead causes its toxic effects, 
that is disruption of heme synthesis or 2) that reticulo¬ 
cytes themselves are associated with a high ALA. Sup¬ 
position 1 is definitely more likely as all patients 
with reties above 2% (patients# 15, 41, 57, 59) had 
both ALA and Pb elevated, while many other patients (# 19, 
23, 25, 45, 56, 60, 63, 64) with elevated ALA and Pb had 
reties less than 1.5%. It seems that since ALA correl¬ 
ated well with % reties while Pb did not it appears 
that the reticulocytosis is probably an effect of Pb 
intoxication as is the level of ALA. Therefore, ALA is 
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In summary it is difficult to say whether ALA or Pb 
correlates best with the other parameters in Figure 4. 
Both correlate reasonably well with hemoglobin although 
lead does so to a better extent. Both correlate poorly 
with fYlCHC and % saturation, ALA correlates better with 
reticulocytes than does Pb as explained above. Therefore* 
ALA is probably a better indicator of the effect of lead 
than is the lead level itself* while the lead level is 
the better estimator of recent absorption. 
F lourescytes: 
Figures 6 and 7 correlate flourescytes against Pb 
and ALA, In figure 6 there were 12 abnormal leads, 2 of 
which had no flourescence or there were 2 of 12 (16%) 
false negatives. Comparing flourescytes vs ALA in 
Figure 7 it can be seen that of the 10 positive ALAs 
2, or 20%, had false negatives. Therefore, if floures¬ 
cence was a screening test 16-20% of the patients would 
have false negatives, that is, they would be called nor¬ 
mal while having either ALA or Pb abnormal. 
There were also 2 false positives in each case, there¬ 
by giving 16-20% of the patients with positive floures¬ 
cytes while having negative Pb or ALA, Hence, about one- 
fifth of the patients would be needlessly worked up. 
Further examination of the false negatives show: 
the 4 false negative points actually represent three 
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patients (# 25,41,42). In these3 patients # 41 has both 
Pb and ALA abnormal and is, therefore, a real false neg¬ 
ative. Patient # 25 had an abnormal ALA and a normal Pb 
and is only a false negative against one parameter. Pat¬ 
ient # 42 had an abnormal lead and no ALA done so it, too, 
is a false negative against one criterion. Of note is 
that all the abnormal values in these false negatives are 
close to the normal ranges (# 25- A LA= .103, Pb= .048; 
# 41- Pb = .069, A LA = .103; # 42- Pb^ .063). It can 
then be seen that the false negatives do exist but they 
are in the ALA and Pb range that is just above the 
normal limit. 
In summary, then, there is a definite 16-20% risk 
of false negatives using flourescytes as a screen. 
However, none of these come in severely intoxicated 
patients, that is those with very high leads or ALAs. 
Again, a larger sample would help but we can imply that 
flourescytes can be used as a screen but a definite risk 
is involved. Serial measurements were not done and it 
would be interesting to see whether or not these child¬ 
ren would have developed positive flourescytes later. 
Another interesting point is suggested by looking 
at the distribution of points in Figures 6 and 7. It 
seems as if the number of flourescytes goes up as the 
ALA value is higher. Most of the patients with signifi¬ 
cantly high ALAs have a high percentage of flourescytes. 
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On the contrary, with lead there are some very high 
values with only a small percent of flourescytes. These 
observations are admittedly just casual and,as noted, quan¬ 
tification is difficult. However, if it is as it appears, 
the ALA correlates better with flourescytes than does 
lead, which is understandable as both ALA and flourescytes 
measure the effect of lead on heme synthesis. 
Basophilic stippling: 
Figure 8 shows the occurrence of basophilic stip¬ 
pling in patients with elevated Pb and elevated ALA. 
Stippled cells are seen in 3 of 7 or 30% of patients 
with elevated lead and 3 of 5 or 38% of patients with 
elevated ALA. The three patients with basophilic stip¬ 
pling have both ALA and Pb elevated. The percentage of 
intoxicated patients having basophilic stippling in our 
study is similar to the 30% (5) to 60% (6,32,36) found 
in the literature. 
Fiqure 11 shows the comparative occurrence of flour¬ 
escytes and basophilic stippled red blood cells. The 
data here show that whenever there is basophilic stip¬ 
pling there is also flourescence; there is never basoph¬ 
ilic stippling without floureecence; and flourescence 
occurs when stippling does not. Therefore, if flourescytes 
are screened for there seems to be no need to look for 
basophilic stippling. 
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flur information suggests what was suggested pre¬ 
viously, that is, that the finding of basophilic 
stippled cells should arouse suspicion of lead intox¬ 
ication and that further studies should be done (34). 
With 40-70% false negatives it is certainly not a useful 
test. Although there are no false positives here, baso¬ 
philic stippled cells are also found in other situat¬ 
ions (27,31) and are not specific for lead intoxication. 
Pica: 
figure 9 shows the occurrence of pica in our study. The 
finding of pica in about 70% of our patients is due to 
the bias of the study which specifically screened patients 
with pica. It can be seen that with either ALA or Pb 
there were no patients with abnormal values that did not 
have pica, and about 60% of those with normal values had 
pica. These results agree with the literature in that 
10-30% (1,4,17) of patients with pica have evidence of 
lead intoxication. In addition we showed that all pat¬ 
ients with intoxication had pica- a not unexpected 
finding. 
X-ray: 
The X-ray results are in Figure 10. The value 
of doing abdominal or bone X-rays is questioned, first 
because radiation is dangerous in young children,and 
second because the results of the X-ray are not particularly 
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useful. The abdominal X-ray will be discussed first. 
In this group all but one of the patients with negative 
Pb or ALA had a negative X-ray thereby giving the patients 
needless radiation when blood tests gave the same result. 
The one false negative is obviously of no value. Of the 
positive X-rays 40% were false positives with lead and 
22% were false positives with ALA, Since two of the 
false positives with Pb did not have ALAs done there is 
an excellent chance that these would have had normal 
ALA values thereby raising the ALA false positives to 44%. 
Therefore, almost half of the patients with positive 
abdominal films did not have evidence of intoxication so 
blood tests would have to be done to prove whether or not 
the patient was intoxicated. It can thus be seen that 
a patient should neither be treated for a positive X-ray 
nor not treated for a negative one, hence, this seems to 
be a needless test. The results of the wrist X-rays 
are from a smaller population but they appear to have as 
little use as do the abdominal films. Here, especially, 
there are so many patients that were true negatives (63- 
73%) that could have been spared the radiation and had 
a simple blood test instead. Half of the two positives 
were false positives, hence even a positive wrist X-ray 
needs chemical verification. UJe, then, agree with 
Sartain's conclusions (51) mentioned previously: that 
x-ray findings should be a secondary consideration and 
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that the presence of x-ray findings should not presume 
intoxication nor should their absence preclude it. Taking 
this one step further there seems to be no need or use in 
doing x-rays at all. 
CSF: 
Figure 12, which compares CSF vs Pb, ALA, and flour- 
escytes, suggests that one cannot tell if central nervous 
system damage has occurred ( as measured by CSF protein) 
by the presence of abnormal values of any of the three 
major parameters. The two patients who had elevated 
CSF protein had all 3 parameters in the abnormal range, 
yet 5 other patients with all 3 parameters abnormal had 
normal CSF protein. 
Hb-Pb : 
Figure 13 shows a copy of one of the electrophor¬ 
esis patterns that included the only two patients that 
had Hb-Pb. As can be seen both patients had abnormal 
Pb, ALA, and flourescyte values. There were, however, 
many patients with abnormal parameters that did not have 
Hb-Pb. Presence of Hb-Pb is an interesting phenomenon 
of which observers should be aware when interpreting 
electrophoretic patterns of anemic children who may 
have plumbism. It has little use as a screening device 
due to the time involved, and to the many false neg¬ 
atives present. 
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There is little to be gained by urine screening. 
Patients with severe lead intoxication shoul have urine 
protein and glucose measured as a baseline, and this is 
usually done when they are admitted to the hospital. 
There seems to be little to be gained by assaying 
urinary aminoacids as there were no positives in the 
severely intoxicated patients who were tested. 
Uric acid: 
None of the patients had elevated uric acids. 
Since this is probably a phenomenon of chronic ingest¬ 
ion (44,45,46) this result is not unexpected. 
Conclusions: 
Some final conclusions about the different possible 
screening tests will now be drawn. Lead vs ALA vs flour- 
escytes will be discussed here and all the final conclu¬ 
sions will be listed in the Summary. 
The comparison of ALA vs Pb as the "true" parameter 
showed a "draw", that is the same number of false neg¬ 
atives (8%) occurs when each is tested against the other. 
From comparison of ALA and Pb to hemoglobin, reticulo¬ 
cytes and flourescytes it appears that the Pb level is a 
better measurement of recent ingestion while ALA is a 
better measurement of the toxic effects of lead. 
The flourescytes gave approximately the same 
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number of false negatives when used as a screen with 
lead as the standard (2 of 12 or 16% false negatives) 
and with ALA as the standard (2 of 10 or 20%). These, 
however, occurred in lead and ALA ranges just outside the 
normal range. There is, thus, a slightly better chance 
of having false negatives using flourescytes as a screen 
than if either ALA or Pb is used to screen the children. 
Consideration will now be given as to which of the 
three is a "good test" according to the criteria listed 
earlier in the discussion; 1)complexity-Lead requires 
12 ml of blood and at least 2 days before results return 
since the blood must be sent to the state lab. ALA 
requires only 5ml of blood (2=3 ml of plasma). The 
test itself has many steps and it takes about 2 hours 
to assay ALA in 6 patients and a control. The results, 
however, are attainable within hours. Flourescytes 
would require only a capillary tube of blood making 
only a fingerstick necessary rather than the venipunct¬ 
ure required for Pb and ALA. It is a simple test to do 
once one learns how to use a UV scope and a sample can 
be screened in a matter of minutes. The major problems 
here are in the availability of a UV scope and in the 
fact that once the scope is turned off it must remain off 
for 2 hours. 2)reprodueibility- Pb and ALA are reproduc¬ 
ible to within reasonable limits- Pb +/- 0.01 mg, ALA +/- 5%. 
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All samples from a tube of blood will give flourescence 
if it is present in that patient. 3) sampling- As suggest¬ 
ed in 1 it is easy to get samples for flourescytes as 
only a finqerstick is needed. ALA and Pb require veni¬ 
punctures with Pb needing 12 ml. 4) rapidity of results- 
Flourescyte screening requires a few minutes to a few 
hours depending on the availability of the UV scope. 
ALA can be done within hours; Pb requires days. 5) 
specificity- Lead levels reflect ingestion of lead; ALA 
and flourescytes reflecr the effects of lead. 
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Summary 
It is impossible to categorically call one test 
the best screening test. The evidence will be summar¬ 
ized below so the reader can be aware of the advantages 
and risks of each. 
1 ) 66 patients were screened for lead intoxication. 
On the basis of a bias selection 20-25% had evidence 
of lead intoxication. 
2) Neither ALA nor lead has a particular advantage over 
the other as far as the number of false negatives is 
concerned. 
3) Flourescytes has slightly more false negatives than 
ALA or Pb. These false negatives occur in ranges of 
A LA and Pb that are just above the normal. 
4) Pb levels appear to reflect recently ingested lead. 
ALA and flourescytes reflect the effects of lead. 
5) Flourescytes is' the easiest test to do and it yields 
rapid results. ALA is fairly rigorous to do but 
yields results in the same day. Pb is done by the 
the state lab but two or more days are required for 
results. All are reasonably reproducible. 
6) Pica- 30% of the patients with pica had evidence of 
lead intoxication. 
7) Hemoglobin, hematocrit, indices- These are not specific 
but may indicate patients that should be screened. 
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8) Basophilic stippling- This is not specific and is 
not worth looking for as the other parameters pick 
up the same patients* If it is found on a routine 
smear more definitive tests should be done, 
9) Iron, iron binding capacity, % saturation- These add 
little to the evaluation of lead intoxication but 
may indicate a concommitant iron deficiency, 
10) Urine- Baseline protein and glucose determinations on 
patients admitted for intoxication would be useful. 
Aminoacid screening is time consuming, costly, and 
not helpful. 
11) Uric acid- All the values were normal. Since it is 
elevated only in chronic ingestion it is not worth 
doing in children. 
12) Cerebrospinal fluid- Lumbar punctures should be done 
in the presence of severe intoxication especially when 
signs and symptoms of CNS damage are present. The 
ALA, Pb and flourescyte values do not appear to be of 
help in choosing who to tap, 
13) Hemoglobin electrophoresis- In screening children for 
causes of anemia one should be aware of the fact that 
a Hb~A3 (Hb-Pb) band may appear in lead intoxicated 
patients. It is an interesting finding but probably 
not worth looking for routinely in lead poisoned 
patients, 
roi l ns.+ imr. -j-noo n eisoibni vsm 
onineeiDe biosonjtoiA 
.neiblirlo ni pniob 
aonejpnrrq 9rii ni 
'io s.ioiqrcys bne eopie 
■ 
. qei oi orl'ju pnisoorio ni qlsrl 
-eies'oriqcriioel 8 nidoioomsH ('€t 
f Iffien5 Id 8S2US0 
.2Jneiieq 
o pni>laoI rlinow ion 
.sinpiisq 
59 
14) X-rays of the abdomen and long bones- Neither 
positive nor negative x-rays aid in the evaluation 
or management of patients. Since thereis a hazard 
to radiation x-rays should be omitted. 















































Appendix 1_- "raw" data 
Age 
fionths 
Hqb Hct me hc Reties Basoph 
stipp1 
Fe IBC 
91 13.0 37 35 - - - - 
17 - - - - - 67 493 
40 - - - - - 40 346 
45 13.0 36 35 0.2 - 87 394 
25 11 .6 37 31 - - 77 407 
57 12.5 37 31 0.1 - 63 452 
22 11 .4 35 32 1 .2 - 65 446 
34 11 .6 38 30 1 .9 0 70 356 
17 12.2 38 32 1 .0 0 60 409 
48 - - - - - 120 280 
32 11 .4 38 30 1 .2 0 106 467 
31 12.2 37 33 0.5 0 51 443 
22 12.4 38 33 1 .4 0 40 388 
34 7.8 30 26 - - 28 516 
31 10.3 35 30 3.0 1 57 492 
19 12.0 38 32 0.4 0 81 363 
16 10.9 37 29 0.4 0 61 461 
23 12.0 40 30 0.8 0 63 511 
40 10.0 34 31 1 .5 0 - - 
66 12.9 42 31 0.5 0 51 4 72 
49 12.9 42 31 1 .0 0 58 341 
28 10.0 36 28 1 .7 0 - - 
47 12.0 36 36 1 .6 - - - 
33 13.5 39 35 1 .0 0 115 314 
^neiieP 
n.cr 
■ • o.cr 
e.sr 
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at Het 35 






.025 .087 0 - no 
- .078 0.5 - 
- - 0 - neq neq 
.051 .073 0 - neq neq 
.02 - 0 - 
.055 0 - pos neq 
.042 - 0 - yes neq - 
.073 - 2 3.3 yes 
.031 - 0 2.7 no pos neq 
- .062 0 4.1 
.039 - 0 6.0 no 
.04 - 0 4.5 yes 
.049 - 0 - yes 
.03 7 .067 0 4.1 yes 
.069 .097 35 - yes pos - 
.044 .057 0 3.4 yes 
.04 .093 0 4.0 yes 
.037 - 0 3.4 yes 
.049 .092 0 - yes 
.022 - 0 3.4 yes neq neq 
.044 .075 0 3.5 
.041 - 0 - no 
.061 .11 - - 














































Aqe H£b Hct 
62 
me HC Reties Basoph Fe IB C % s 
onths 
25 10.0 35 29 1 .2 
stipp 1 
0 51 351 10 
30 10.3 36 29 0.9 0 43 543 8 
14 9.0 33 27 1 .4 0 16 555 3 
13 8.8 33 27 2.5 0 - - - 
9 7.0 29 25 0.9 0 27 63 6 4 
33 13.7 38 36 0.5 0 - - - 
50 12.2 38 32 2.0 0 134 450 30 
14 11.6 37 31 1 .6 0 88 390 23 
47 12.0 38 32 0.8 0 87 264 33 
25 10.3 35 29 1.8 0 21 629 3 
11 12.0 35 34 0.8 - 66 409 16 
32 12.6 39 32 1 .0 0 56 346 16 
32 12.2 37 33 1 .4 0 77 367 21 
20 11 .1 37 30 0.4 0 66 439 15 
23 9.4 33 28 0.7 0 - - - 
23 12.4 36 34 0.8 0 - - - 
24 14.2 40 35 2.6 0 - - - 
If 12.2 41 30 1 .2 0 65 438 15 
29 7.8 23 34 0.5 0.5 116 466 25 
II 10.0 35 29 1 .4 0 - - - 
25 10.5 36 29 1 .2 0 - - - 
26 11.8 33 36 1 .0 0 50 396 13 
73 11 ,1 37 30 0.4 0 69 375 1 8 
44 12.0 37 32 0.6 0 60 432 14 
inei cfsP 
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at Het 35 






.048 .103 0 3.4 yes pos 
.041 .072 0 4.8 yes pos neg 
.056 - 1.5 - 
.028 .050 0 - yes 
.051 .067 0 5.8 no 
.034 .058 0 - yes 
.034 .078 0 5.5 no neg pos 
.03 .06 0 3.7 no 
.031 .053 0 5.2 no neg 
.048 .087 0 - yes 
.037 .053 0.2 5.4 yes pos neg 
.033 .083 0 2.8 yes neg neg 
.03 .083 0 3.8 yes neg neg 
.025 .050 0 5.4 no 
.053 .057 0 - yes 
.041 - 0 4.2 yes 
.069 .103 0 - yes neg 
.063 - 0 - yes 
.11 .117 42 2.5 pos 
.069 - 40 - 
.051 .058 0 - yes pos 
.056 .066 0 2.8 yes 
.04 .07 0 3.0 no 
.03 .05 0 4.3 yes 
Wise. 
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Hqb Hot MCHC Retie Basoph 
stipp1 
Fe IB C % sat 
49 58 10.5 34 31 1 .0 0 34 326 10 
50 69 12.0 37 32 0.8 0 27 382 7 
51 30 14.4 43 33 0.6 0 96 4 73 20 
52 37 10.0 32 31 1 .4 0 66 4 73 14 
53 30 11 .4 37 31 1 .6 0 39 496 8 
54 50 8.6 33 26 1.0 0 28 600 5 
55 21 - - - 0.6 0 28 569 5 
56 51 14.6 41 28 1 .0 0 46 3 03 1 5 
57 1 8 9.0 29 31 2.0 0 48 436 11 
58 32 7.4 25 30 1 .0 0.25 24 571 4 
59 38 7.8 27 29 2.5 0 25 507 5 
60 21 9.8 33 30 1 .8 0 35 495 7 
61 15 9.5 31 31 - - - - - 
62 10 7.9 29 27 - - - - - 
63 15 9.8 32 31 1 .0 0 34 486 7 
64 43 13.2 36 37 1 .2 - 41 308 13 
65 24 8.0 27 30 1 .2 - 19 560 4 
66 24 12.0 35 35 _ 66 384 1 7 
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Patient Lead ALA F lour. Uric Pica X -ray Wise. 
at Hct 35 acid ab d wrist 
49 .049 - 0 3.0 
50 .05 .058 0 5.3 
51 .017 - 0 3.5 yes 
52 .046 .057 0 4.1 no Hb-AC 
53 .03 .075 0 2.8 no 
54 .045 .05 0 3.2 no 
55 - ,07 0 2.1 yes 
56 .045 .075 0 3.9 yes 
57 .12 .099 1 .5 3.8 yes pos nep CSF prot 
= 58 




59 .165 .15 14 3.1 yes pos nl CSF 
Hb-A3 
60 .21 .12 1 3.6 yes pos nl CSF 
urine 1+ q luc 
61 .14 .142 10 4.7 yes pos nl CSF 
62 .46 .125 30 3.6 yes pos pos urine tr prot 
1 + g luc 
63 .023 .092 0 3.5 no nl CSF 
64 .051 .091 0 3.9 
65 .095 .083 - 3.9 
66 .032 0 4.4 no 
insiieO 
PfcCi. G A 
850. 50. 
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